Syn-Ake

Overview

Syn-Ake is a synthetic tripeptide analog of Waglerin-1, the main neurotoxic peptide from the venom of the temple pit viper Tropidolaemus wagleri. Like its natural template, Syn-Ake antagonizes muscular nicotinic acetylcholine receptors (nAChRs) in a reversible, competitive manner, reducing the intensity and frequency of facial muscle contractions without causing true neurotoxicity. Applied topically, it is marketed as a 'snake venom in a cream' cosmeceutical for smoothing expression lines, and clinical studies support improvements in wrinkle appearance.

Mechanism of Action

Syn-Ake binds the muscular nicotinic acetylcholine receptor (nAChR, α1β1γδ subunit composition) at the acetylcholine binding site, acting as a competitive reversible antagonist. This reduces postsynaptic membrane depolarization in response to acetylcholine release, attenuating muscle contraction strength at neuromuscular junctions in facial skin. The effect is dose-dependent, reversible, and localized to the dermis upon topical application, unlike systemic nAChR antagonists.

Potential Benefits

• Reduction of wrinkle depth in expression lines
• Reversible muscle relaxation at neuromuscular junctions
• Clinical studies show improvement in glabellar and periorbital lines
• Complementary mechanism to Argireline (pre/post-synaptic combination)
• Good cosmeceutical safety profile

Research Dosage Notes

The following reflects doses used in published research studies. This is not medical advice.

Topical: 4% solution in cosmeceutical formulations based on clinical studies.

Amino Acid Sequence

Side Effects & Safety

• Well-tolerated topically
• Rare skin sensitization

Synergistic Compounds

The following compounds have been studied alongside Syn-Ake for potential complementary or synergistic effects:

Related Peptides

Learn More

References & Further Reading

• [object Object]